The Proteome of Sickle Cell Disease: Insights from Exploratory Proteomic Profiling

Overview

Journal Expert Rev Proteomics

Publisher Informa Healthcare

Date 2010 Dec 15

PMID 21142886

Citations 14

Authors

Susan Yuditskaya

Anthony F Suffredini

Gregory J Kato

Affiliations

Soon will be listed here.

Abstract

The expanding realm of exploratory proteomics has added a unique dimension to the study of the complex pathophysiology involved in sickle cell disease. A review of proteomic studies published on sickle cell erythrocytes and plasma shows trends of upregulation of antioxidant proteins, an increase in cytoskeletal defects, an increase in protein repair and turnover components, a decrease in lipid raft proteins and apolipoprotein dysregulation. Many of these findings are consistent with the pathophysiology of sickle cell disease, including high oxidant burden, resulting in damage to cytoskeletal and other proteins, and erythrocyte rigidity. More unexpected findings, such as a decrease in lipid raft components and apolipoprotein dysregulation, offer previously unexplored targets for future investigation and potential therapeutic intervention. Exploratory proteomic profiling is a valuable source of hypothesis generation for the cellular and molecular pathophysiology of sickle cell disease.

Citing Articles

Whole Blood Transcriptome Analysis in Congenital Anemia Patients.

Sanchez-Villalobos M, Campos Banos E, Martinez-Balsalobre E, Navarro-Ramirez V, Videla M, Pinilla M Int J Mol Sci. 2024; 25(21).

PMID: 39519257 PMC: 11546763. DOI: 10.3390/ijms252111706.

Advances in non-viral mRNA delivery to the spleen.

Narasipura E, Fenton O Biomater Sci. 2024; 12(12):3027-3044.

PMID: 38712531 PMC: 11175841. DOI: 10.1039/d4bm00038b.

Clinical Biomarkers of Acute Vaso-Occlusive Sickle Cell Crisis.

Khurana K, Mahajan S, Acharya S, Kumar S, Toshniwal S Cureus. 2024; 16(3):e56389.

PMID: 38633967 PMC: 11022002. DOI: 10.7759/cureus.56389.

Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease.

Lance E, Faulcon L, Fu Z, Yang J, Whyte-Stewart D, Strouse J Proteomics Clin Appl. 2021; 15(5):e2100003.

PMID: 33915030 PMC: 8666096. DOI: 10.1002/prca.202100003.

A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic.

Yasara N, Premawardhena A, Mettananda S Orphanet J Rare Dis. 2021; 16(1):114.

PMID: 33648529 PMC: 7919989. DOI: 10.1186/s13023-021-01757-w.

References

Jison M, Munson P, Barb J, Suffredini A, Talwar S, Logun C . Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood. 2004; 104(1):270-80. PMC: 5560446. DOI: 10.1182/blood-2003-08-2760. View

Fowler V, Sussmann M, Miller P, Flucher B, Daniels M . Tropomodulin is associated with the free (pointed) ends of the thin filaments in rat skeletal muscle. J Cell Biol. 1993; 120(2):411-20. PMC: 2119515. DOI: 10.1083/jcb.120.2.411. View

Gladwin M, Sachdev V, Jison M, Shizukuda Y, Plehn J, Minter K . Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004; 350(9):886-95. DOI: 10.1056/NEJMoa035477. View

Ren H, Ghebremeskel K, Okpala I, Lee A, Ibegbulam O, Crawford M . Patients with sickle cell disease have reduced blood antioxidant protection. Int J Vitam Nutr Res. 2008; 78(3):139-47. DOI: 10.1024/0300-9831.78.3.139. View

Perelman N, Selvaraj S, Batra S, Luck L, Erdreich-Epstein A, Coates T . Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood. 2003; 102(4):1506-14. DOI: 10.1182/blood-2002-11-3422. View

Hunt A, Fenn H, Clark G, Wright M, Postle A, McMaster C . Lipidomic analysis of the molecular specificity of a cholinephosphotransferase in situ. Biochem Soc Trans. 2004; 32(Pt 6):1060-2. DOI: 10.1042/BST0321060. View

Kaul D, Hebbel R . Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000; 106(3):411-20. PMC: 314325. DOI: 10.1172/JCI9225. View

Platt O, Falcone J, Lux S . Molecular defect in the sickle erythrocyte skeleton. Abnormal spectrin binding to sickle inside-our vesicles. J Clin Invest. 1985; 75(1):266-71. PMC: 423435. DOI: 10.1172/JCI111684. View

Chang T, Kakhniashvili D, Goodman S . Spectrin's E2/E3 ubiquitin conjugating/ligating activity is diminished in sickle cells. Am J Hematol. 2005; 79(2):89-96. DOI: 10.1002/ajh.20351. View

10.

Frenette P . Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation. 2004; 11(2):167-77. View

11.

Ghatpande S, Goodman S . Ubiquitination of spectrin regulates the erythrocyte spectrin-protein-4.1-actin ternary complex dissociation: implications for the sickle cell membrane skeleton. Cell Mol Biol (Noisy-le-grand). 2004; 50(1):67-74. View

12.

Hsu Y, Zimmer W, Goodman S . Erythrocyte spectrin's chimeric E2/E3 ubiquitin conjugating/ligating activity. Cell Mol Biol (Noisy-le-grand). 2005; 51(2):187-93. View

13.

Raghavachari N, Xu X, Munson P, Gladwin M . Characterization of whole blood gene expression profiles as a sequel to globin mRNA reduction in patients with sickle cell disease. PLoS One. 2009; 4(8):e6484. PMC: 2714456. DOI: 10.1371/journal.pone.0006484. View

14.

Hebbel R . The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization. Semin Hematol. 1990; 27(1):51-69. View

15.

Reiter C, Wang X, Tanus-Santos J, Hogg N, Cannon 3rd R, Schechter A . Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002; 8(12):1383-9. DOI: 10.1038/nm1202-799. View

16.

Manfredini V, Lazzaretti L, Griebeler I, Santin A, Brandao V, Wagner S . Blood antioxidant parameters in sickle cell anemia patients in steady state. J Natl Med Assoc. 2008; 100(8):897-902. DOI: 10.1016/s0027-9684(15)31402-4. View

17.

Schwartz R, Rybicki A, Heath R, Lubin B . Protein 4.1 in sickle erythrocytes. Evidence for oxidative damage. J Biol Chem. 1987; 262(32):15666-72. View

18.

Gambero S, Canalli A, Traina F, Albuquerque D, Saad S, Costa F . Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties. Eur J Haematol. 2007; 78(2):144-51. DOI: 10.1111/j.1600-0609.2006.00788.x. View

19.

An X, Takakuwa Y, Nunomura W, Manno S, Mohandas N . Modulation of band 3-ankyrin interaction by protein 4.1. Functional implications in regulation of erythrocyte membrane mechanical properties. J Biol Chem. 1996; 271(52):33187-91. DOI: 10.1074/jbc.271.52.33187. View

20.

Katagiri T, Ozaki K, Fujiwara T, Shimizu F, Kawai A, Okuno S . Cloning, expression and chromosome mapping of adducin-like 70 (ADDL), a human cDNA highly homologous to human erythrocyte adducin. Cytogenet Cell Genet. 1996; 74(1-2):90-5. DOI: 10.1159/000134389. View